Contact Information:

Media Contact

Vanessa Wasta
wasta@jhmi.edu
410-614-2916

Twitter: HopkinsMedicine

http://www.hopkinsmedicine.org




Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.

PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Researchers thwart cancer cells by triggering 'virus alert'


2015-08-27
(Press-News.org) Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.

In a report on the work published in the Aug. 27 issue of Cell, the Johns Hopkins-led research team says it has found a core group of genes related to both a viral defense warning system and susceptibility to a demethylating drug called 5-azacytidine that chemically alters their ability to operate through a process called demethylation.

A study with similar findings authored by Daniel De Carvalho, Ph.D., at the Ontario Cancer Institute/Princess Margaret Hospital, and Peter Jones, Ph.D., D.Sc., director of research at the Van Andel Institute, focused on the ability of DNA demethylating agents to target colorectal cancer stem cells, is published in the same journal issue.

Tumors are known to co-opt cellular gene-silencing systems that add tiny chemicals called methyl groups to areas of genes, thereby turning off the affected gene function. Such "epigenetic" control normally occurs in many genes, including ones that contain DNA leftover from previous exposures to viruses. When epigenetic control of these genes is removed, the virus-laden gene sequences are activated and trigger an alert to immune system cells that a virus has invaded.

"A main barrier to immune therapy success has been the tumor's ability to keep the immune system from functioning against the cancer," says study leader Stephen Baylin, M.D., the Virginia and Daniel K. Ludwig Professor of Cancer Research at the Kimmel Cancer Center. "The immune cells are there, but like an unarmed army, they hang around and do nothing. However, certain epigenetic processes that silence such viral defense genes can be reversed in tumor cells with a demethylating drug, making immunotherapies work more effectively to kill cancer cells."

For their new study, Baylin and his team worked with laboratory-grown cell lines from human ovarian, colon and skin cancer, and the team led by De Carvalho worked with colon cancer cells. In the cancer cell lines, both teams found that the viral defense pathway can be turned on when the cells were exposed to 5-azacytidine. Once the pathway is activated, Baylin adds, the tumor cells release signaling proteins called interferons that rouse other cancer-fighting cells in the immune system.

Then, the Johns Hopkins team created a gene signature of the viral defense pathway. In tumor samples available from the National Cancer Institute's Cancer Genome Atlas project, the scientists used the gene signature to distinguish between tumor samples with high expression of the pathway from those with low expression. Those with high expression may respond to certain immunotherapy drugs without the aid of 5-azacytidine, but those with low expression levels may need the epigenetic drug to boost response to immunotherapy, says Baylin.

Looking for the connection between the pathway's expression and immunotherapy drug response, the Johns Hopkins investigators and their colleagues focused on expression levels of the viral defense pathway in tumor cells from 21 patients with melanoma treated with the immune therapy drug ipilimumab at Memorial Sloan Kettering Cancer Center. They found high expression levels in the cells of seven of eight of those patients who had responded well to ipilimumab. Cells from all 12 patients with limited response to ipilimumab had low expression of the viral defense pathway.

In a melanoma mouse model in which ipilimumab alone was partially effective, adding 5-azacytidine to ipilimumab triggered a better tumor response.

"Our findings further decipher the mechanisms that lead to this tumor cell immune reaction and offer a way to potentially boost the success of immune therapies in patients with cancer," says Baylin, who first became interested in the immune system's connection to 5-azacytidine when laboratory research and clinical trials at Johns Hopkins hinted at the drug's ability to prevent cancer cells' proliferation when combined with immunotherapy.

Baylin and his colleagues say that, if their findings are confirmed and extended in clinical trials, the 5-azacytidine treatment could be followed by ipilimumab or other types of immunotherapy called checkpoint blockade, which lower cancer cells' defenses and allow immune system cells to see and destroy them.

"Treatment with 5-azacytidine activates interferon signaling in tumor cells and, when followed by checkpoint blockade immune therapy, the immune cells could go into increased action against the cancer," says Johns Hopkins research fellow and lead author Katherine Chiappinelli, Ph.D.

Baylin and Chiappinelli caution that clinical trials will take time to learn how effective the strategy of alerting the viral defense pathway might be. But the strategy holds promise, he says, for patients who have cancers with low expression of the pathway.

INFORMATION:

In addition to Baylin and Chiappinelli, other investigators included Pamela L. Strissel, Alexis Desrichard, Huili Li, Christine Henke, Benjamin Akman, Alexander Hein, Neal S. Rote, Leslie M. Cope, Alexandra Snyder, Vladimir Makarov, Sadna Buhu, Dennis Slamon, Jedd D. Wolchok, Drew M. Pardoll, Matthias W. Beckmann, Cynthia A. Zahnow, Taha Mergoub, Timothy A. Chan and Reiner Strick. In addition to the Johns Hopkins Kimmel Cancer Center, participating institutions included the University-Clinic Erlangen in Germany, Memorial Sloan Kettering Cancer Center, Case Western Reserve University and Jonsson Comprehensive Cancer Center at UCLA.

Baylin is a consultant for MDxHealth, which makes an assay procedure that is licensed to MDxHealth by The Johns Hopkins University. Baylin and the university are entitled to royalty shares from sales of the assay. Pardoll is a consultant for Pfizer and Amplimmune. The research was funded by the National Institutes of Health's National Cancer Institute (CA058184, F32CA183214), the Stand Up To Cancer Epigenetic Dream Team, the Hodson Trust, the Samuel Waxman Cancer Research Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, a Department of Defense Teal Award (BC031272-SBB), the Pershing Square Sohn Cancer Research Alliance, the STARR Cancer Consortium, the Ludwig Foundation and German Cancer Aid.

Johns Hopkins Medicine
Media Relations and Public Affairs
Media contacts:
Patrick Smith, 410-955-8242, pjsmith@jhu.edu
Jania Matthews, 410-955-5384, jmatth27@jhmi.edu


ELSE PRESS RELEASES FROM THIS DATE:

Getting a picture of the molecules in a cell in just minutes

2015-08-27
Understanding exactly what is taking place inside a single cell is no easy task. For DNA, amplification techniques are available to make the task possible, but for other substances such as proteins and small molecules, scientists generally have to rely on statistics generated from many different cells measured together. Unfortunately, this means they cannot look at what is happening in each individual cell. Now, thanks to seven years of work done at the RIKEN Quantitative Biology Center and Hiroshima University, scientists can take a peek into a single plant cell and--within ...

Mammary gland is shaped by adaptive immune system during development

2015-08-27
In experiments with mouse tissue, UC San Francisco researchers have discovered that the adaptive immune system, generally associated with fighting bacterial and viral infections, plays an active role in guiding the normal development of mammary glands, the only organs--in female humans as well as mice--that develop predominately after birth, beginning at puberty. The scientists say the findings have implications not only for understanding normal organ development, but also for cancer and tissue-regeneration research, as well as in the highly active field of cancer immunotherapy, ...

Cervical pessary doesn't reduce rate of preterm birth or neonatal complications in twin gestatations

2015-08-27
Philadelphia, PA, Aug 27, 2015 - Having twins accounts for only 1.5% of all births but 25% of preterm births, the leading cause of infant mortality worldwide. Successful strategies for reducing singleton preterm births include prophylactic use of progesterone and cervical cerclage in patients with a prior history of preterm birth. To investigate whether the use of a cervical pessary might reduce premature births of twins, an international team of researchers conducted a large, multicenter, international randomized clinical trial (RCT) of approximately 1200 twin pregnancies. ...

To track winter flounder, UNH researchers look to ear bones

To track winter flounder, UNH researchers look to ear bones
2015-08-27
DURHAM, N.H. - Researchers at the University of New Hampshire are turning to an unusual source --otoliths, the inner ear bones of fish -- to identify the nursery grounds of winter flounder, the protected estuaries where the potato chip-sized juveniles grow to adolesence. The research, recently published in the journal Transactions of the American Fisheries Society, could aid the effort to restore plummeting winter flounder populations along the East Coast of the U.S. In addition to showing the age of a fish, much like the rings in the cross-section of a tree, otoliths ...

NASA data shows Hurricane Ignacio's very cold cloud tops indicate quick strengthening

NASA data shows Hurricane Ignacios very cold cloud tops indicate quick strengthening
2015-08-27
When cloud top temperatures get colder, the uplift in tropical cyclones gets stronger and the thunderstorms that make up the tropical cyclones have more strength. NASA's Aqua satellite passed over Hurricane Ignacio and infrared data revealed cloud top temperatures had cooled from the previous day. Ignacio strengthened to a hurricane at 11 p.m. EDT on August 26. It became the seventh hurricane of the Eastern Pacific Ocean hurricane season. A false-colored infrared image of Hurricane Ignacio was made at NASA's Jet Propulsion Laboratory in Pasadena California, using data ...

HIV particles do not cause AIDS, our own immune cells do

2015-08-27
Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another. HIV can either be spread through free-floating virus that directly infect the host immune cells or an infected cell can pass the virus to an uninfected cell. The second method, cell to cell transmission, is 100 to 1000 times more efficient, and the new study shows that it is only this method that sets off a cellular chain reaction that ends in the newly infected cells ...

Researchers develop framework for value-based pricing of cancer drugs

2015-08-27
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug. The study findings will be published August 27, 2015 in JAMA Oncology. Researchers focused their investigation on a drug called necitumumab, which is awaiting approval from the U.S. Food and Drug ...

21-gene recurrence score and receipt of chemotherapy in patients with breast cancer

2015-08-27
Use of the 21-gene recurrence test score was associated with lower chemotherapy use in high-risk patients and greater use of chemotherapy in low-risk patients compared with not using the test among a large group of Medicare beneficiaries, according to an article published online by JAMA Oncology. National Comprehensive Cancer Network (NCCN) guidelines recommend considering chemotherapy in estrogen receptor (ER)-positive, node-negative breast cancer for all but the smallest tumors. Several studies have suggested the 21-gene recurrence score assay (testing) is cost-effective ...

Safety of microfocused ultrasound with visualization in darker skin types

2015-08-27
Microfocused ultrasound (MFU) treatment to tighten and lift skin on the face and neck appeared to be safe for patients with darker skin types in a small study that resulted in only a few temporary adverse effects, according to a report published online by JAMA Facial Plastic Surgery. Normal aging results in changes in the skin and underlying connective tissue. A system that uses MFU together with ultrasound visualization was developed to treat lax, aging skin. Previous clinical trials have shown the system to be a safe and effective noninvasive aesthetic treatment, according ...

Pitt team identifies cause of resilience to tinnitus, potential drug therapy

2015-08-27
PITTSBURGH, Aug. 27, 2015 - Researchers have identified in an animal model the molecular mechanisms behind resilience to noise-induced tinnitus and a possible drug therapy that could reduce susceptibility to this chronic and sometimes debilitating condition. The findings by a team from the University of Pittsburgh School of Medicine were published online in the journal eLife. Tinnitus is typically induced by exposure to loud noise and causes whistling, clicking, roaring and other phantom sounds. It is estimated that 5 to 15 percent of Americans suffer from tinnitus, said ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Researchers thwart cancer cells by triggering 'virus alert'
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.